120 related articles for article (PubMed ID: 27012120)
1. [Assesment of the ongoing changes among patients diagnosed with subclinical changes of an HPV infection (SPI) as well as changes in the type of CIN 1 and CIN 2].
Wyroba J; Jach R; Huras H; Basta T; Streb J; Hosiawa W; Drabina J
Przegl Lek; 2015; 72(11):622-8. PubMed ID: 27012120
[TBL] [Abstract][Full Text] [Related]
2. Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competing-risks regression models.
Syrjänen K; Shabalova I; Sarian L; Naud P; Longatto-Filho A; Derchain S; Kozachenko V; Zakharchenko S; Roteli-Martins C; Nerovjna R; Kljukina L; Tatti S; Branovskaja M; Branca M; Grunjberga V; Erzen M; Juschenko A; Serpa Hammes L; Podistov J; Costa S; Syrjänen S; ;
Eur J Gynaecol Oncol; 2012; 33(1):5-14. PubMed ID: 22439398
[TBL] [Abstract][Full Text] [Related]
3. Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression.
Liu S; Minaguchi T; Lachkar B; Zhang S; Xu C; Tenjimbayashi Y; Shikama A; Tasaka N; Akiyama A; Sakurai M; Nakao S; Ochi H; Onuki M; Matsumoto K; Yoshikawa H; Satoh T
PLoS One; 2018; 13(2):e0193061. PubMed ID: 29466435
[TBL] [Abstract][Full Text] [Related]
4. Co-factors of high-risk human papillomavirus infections display unique profiles in incident CIN1, CIN2 and CIN3.
Syrjänen K; Shabalova I; Naud P; Derchain S; Sarian L; Kozachenko V; Zakharchenko S; Roteli-Martins C; Nerovjna R; Longatto-Filho A; Kljukina L; Tatti S; Branovskaja M; Branca M; Grunjberga V; Erzen M; Juschenko A; Hammes LS; Costa S; Podistov J; Syrjänen S; ; ;
Int J STD AIDS; 2011 May; 22(5):263-72. PubMed ID: 21571974
[TBL] [Abstract][Full Text] [Related]
5. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.
van Baars R; Griffin H; Wu Z; Soneji YJ; van de Sandt M; Arora R; van der Marel J; Ter Harmsel B; Jach R; Okon K; Huras H; Jenkins D; Quint W; Doorbar J
Am J Surg Pathol; 2015 Nov; 39(11):1518-1528. PubMed ID: 26379150
[TBL] [Abstract][Full Text] [Related]
6. Plasma expression of miRNA-21, - 214, -34a, and -200a in patients with persistent HPV infection and cervical lesions.
Wang H; Zhang D; Chen Q; Hong Y
BMC Cancer; 2019 Oct; 19(1):986. PubMed ID: 31646977
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
[TBL] [Abstract][Full Text] [Related]
8. Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.
Jaisamrarn U; Castellsagué X; Garland SM; Naud P; Palmroth J; Del Rosario-Raymundo MR; Wheeler CM; Salmerón J; Chow SN; Apter D; Teixeira JC; Skinner SR; Hedrick J; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; Bosch FX; de Carvalho NS; Germar MJ; Peters K; Paavonen J; Bozonnat MC; Descamps D; Struyf F; Dubin GO; Rosillon D; Baril L;
PLoS One; 2013; 8(11):e79260. PubMed ID: 24260180
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
[TBL] [Abstract][Full Text] [Related]
10. Type-specific distribution of HPV along the full spectrum of cervical carcinogenesis in Taiwan: an indication of viral oncogenic potential.
Ding DC; Hsu HC; Huang RL; Lai HC; Lin CY; Yu MH; Chu TY
Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):245-51. PubMed ID: 18502563
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the frequency of genetic alterations (LOH/MSI) in patients with intraepithelial cervical lesions with HPV infection: a pilot study.
Migdalska-Sęk M; Karowicz-Bilińska A; Pastuszak-Lewandoska D; Czarnecka KH; Nawrot E; Domańska-Senderowska D; Kiszałkiewicz J; Brzeziańska-Lasota E
Med Oncol; 2016 May; 33(5):51. PubMed ID: 27090798
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants.
Wang SS; Zuna RE; Wentzensen N; Dunn ST; Sherman ME; Gold MA; Schiffman M; Wacholder S; Allen RA; Block I; Downing K; Jeronimo J; Carreon JD; Safaeian M; Brown D; Walker JL
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):113-20. PubMed ID: 19124488
[TBL] [Abstract][Full Text] [Related]
13. Distribution of human papilloma virus genotype prevalence in invasive cervical carcinomas and precancerous lesions in the Yangtze River Delta area, China.
Wang H; Cheng X; Ye J; Xu X; Hong Y; Sui L; You Z; Xie X
BMC Cancer; 2018 Apr; 18(1):487. PubMed ID: 29703167
[TBL] [Abstract][Full Text] [Related]
14. HPV L1 and P16 Expression in CIN1 to Predict Future CIN2.
Liu C; Du H; Wang C; Belinson JL; Yang B; Zhang W; Tang J; Wu R
Int J Gynecol Pathol; 2017 May; 36(3):281-288. PubMed ID: 28277314
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
Aleksioska-Papestiev I; Chibisheva V; Micevska M; Dimitrov G
Med Arch; 2018 Feb; 72(1):26-30. PubMed ID: 29416214
[TBL] [Abstract][Full Text] [Related]
16. Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion.
Zuna RE; Wang SS; Schiffman M; Solomon D
Cancer; 2006 Oct; 108(5):288-97. PubMed ID: 16952155
[TBL] [Abstract][Full Text] [Related]
17. Semi-quantitative HPV viral load in patients with ASC-US cytology: viral load correlates strongly with the presence of CIN but only weakly with its severity.
Lee SJ; Kim WY; Shim SH; Cho SH; Oh IK; Hwang TS; Kim SN; Kang SB
Cytopathology; 2015 Feb; 26(1):19-25. PubMed ID: 24766438
[TBL] [Abstract][Full Text] [Related]
18. Retrospective study of the influence of HPV persistence on outcomes among women with high-risk HPV infections and negative cytology.
Bogani G; Taverna F; Lombardo C; Borghi C; Martinelli F; Signorelli M; Leone Roberti Maggiore U; Chiappa V; Scaffa C; Ditto A; Lorusso D; Raspagliesi F
Int J Gynaecol Obstet; 2017 Jul; 138(1):62-68. PubMed ID: 28388819
[TBL] [Abstract][Full Text] [Related]
19. HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN.
Briolat J; Dalstein V; Saunier M; Joseph K; Caudroy S; Prétet JL; Birembaut P; Clavel C
Int J Cancer; 2007 Nov; 121(10):2198-204. PubMed ID: 17657742
[TBL] [Abstract][Full Text] [Related]
20. Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance.
Insinga RP; Perez G; Wheeler CM; Koutsky LA; Garland SM; Leodolter S; Joura EA; Ferris DG; Steben M; Hernandez-Avila M; Brown DR; Elbasha E; Muñoz N; Paavonen J; Haupt RM;
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):287-96. PubMed ID: 21300618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
